Human uremic plasma increases microvascular permeability to water and proteins in vivo

被引:38
作者
Harper, SJ
Tomson, CRV
Bates, DO
机构
[1] Univ Bristol, New Vet Sch, Dept Physiol, Bristol BS2 8EJ, Avon, England
[2] Univ Bristol, Southmead Hosp, Acad Renal Labs, Bristol, Avon, England
基金
英国惠康基金;
关键词
capillary permeability; uremia; kidney disease; vascular endothelium; cardiovascular disease; transvascular transport;
D O I
10.1046/j.1523-1755.2002.00252.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The risk of cardiovascular disease is significantly higher in patients with long-term uremia than in otherwise healthy adults. This is true even before patients proceed to dialysis, ut the reason why cardiovascular risk is increased is unknown. Transvascular transport of lipids and other macromolecules in both large vessels and the microcirculation has been implicated in generation of cardiovascular disease. Methods. To determine whether patients with long-term uremia have circulating factors that promote increased vascular permeability, we measured the effect of perfusing microvessels with uremic plasma in a non-mammalian model of vascular permeability measurement. Results. Perfusion of frog mesenteric microvessels with dialyzed normal plasma did not result in an increase in either hydraulic conductivity (L-p, permeability of the vessel wall to water) or oncotic reflection coefficient (sigma, permeability to macromolecules, particularly proteins). Perfusion with dialyzed uremic plasma resulted in a very significant increase in vascular permeability to both water (L-p increased 8.8-fold from 4.1 to 36.4 X 10(-7) cm s(-1) cm. H2O-1) and proteins (sigma reduced from 0.93 to 0.53). Conclusions. These results suggest that one or more circulating macromolecules in uremic plasma are able to increase transvascular solute and fluid flux, and may underlie the increased cardiovascular risk found in these patients.
引用
收藏
页码:1416 / 1422
页数:7
相关论文
共 26 条
[1]   Premature cardiovascular disease in chronic renal failure [J].
Baigent, C ;
Burbury, K ;
Wheeler, D .
LANCET, 2000, 356 (9224) :147-152
[2]   Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels [J].
Bates, DO ;
Curry, FE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (06) :H2520-H2528
[3]   Vascular endothelial growth factor and microvascular permeability [J].
Bates, DO ;
Lodwick, D ;
Williams, B .
MICROCIRCULATION, 1999, 6 (02) :83-96
[4]   The chronic effect of vascular endothelial growth factor on individually perfused frog mesenteric microvessels [J].
Bates, DO .
JOURNAL OF PHYSIOLOGY-LONDON, 1998, 513 (01) :225-233
[5]   UREMIA AS A STATE OF IMMUNE DEFICIENCY [J].
BIRKELAND, SA .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1976, 5 (1-2) :107-115
[6]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[7]  
Curry F R, 1994, Microcirculation, V1, P11, DOI 10.3109/10739689409148258
[8]  
Curry FE, 1983, CARDIOVASCULAR PHY P, P1
[9]   Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression [J].
D'Arcangelo, D ;
Facchiano, F ;
Barlucchi, LM ;
Melillo, G ;
Illi, B ;
Testolin, L ;
Gaetano, C ;
Capogrossi, MC .
CIRCULATION RESEARCH, 2000, 86 (03) :312-318
[10]  
FOLEY RN, 1998, AM J KIDNEY DIS S, V12, pS516